About Dermagnostix
Dermagnostix is a Healthcare company based in Freiburg Im Breisgau (Germany) founded in 2018. Molecular diagnostic tests for skin diseases are developed. Dermagnostix offers products and services including PsorX-LabDisk, LabDisk-Analyzer, and Product Pipeline. Its focus areas include Life Sciences, Dermatology, In Vitro Diagnostics Tests and Oncology. Its legal entity is Dermagnostix GmbH.
Company details
Dermagnostix was founded in 2018 as a developer of molecular diagnostic tests focused on skin diseases. The PsorX test is provided for detecting psoriasis and atopic dermatitis through the LabDisk-Analyzer, an in vitro diagnostic instrument. Disposable LabDisk cartridges are utilized, containing all necessary reagents for assays. Additional tests for mycosis fungoides and malignant melanoma are under development in the diagnostics sector.
- Headquarters Freiburg Im Breisgau, Germany
- SectorsHealthcare
- Email••••••••
- Website dermagnostix.com
- Social LinkedIn Instagram YouTube
- Legal Name Dermagnostix Gmbh
- Latest Funding Round$2.83M (USD), Grant
Dec 2022
- Investors
Products & Services of Dermagnostix
Dermagnostix offers a comprehensive portfolio of products and services, including PsorX-LabDisk, LabDisk-Analyzer, and Product Pipeline.
Molecular tool for differentiating psoriasis and eczema in skin samples.
Automated system for molecular workflows in pathology laboratories.
Includes tests like LymphX for advanced skin disease diagnostics.
Apps and channels of Dermagnostix
its YouTube channel Dermagnostix GmbH has 12 subscribers and 7 videos.
Videos from Dermagnostix
The most watched videos on Dermagnostix's YouTube channel, Dermagnostix GmbH (12 subscribers). Click a video to play it here.
More on Dermagnostix GmbH.
Funding Insights of Dermagnostix
- Total Rounds 1
- Last Round Grant — $2.83M
- First Round $2.83M
(Dec 2022)
- Investors Count 1
All 1 funding rounds of Dermagnostix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $2.83M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Dermagnostix
Dermagnostix has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium |
Investor details for Dermagnostix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dermagnostix
3 people are tracked at Dermagnostix (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Natalie Garzorz-Stark | Co-founder And CEO | Leadership |
Ludwig Gutzweiler | Cto, Managing Director | Leadership |
Frank Schwemmer | Experte R&d | Team |
Complete people profiles for Dermagnostix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dermagnostix
2 dated milestones of Dermagnostix across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Dermagnostix is founded.
- Funding First funding round of $2.8M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dermagnostix
Dermagnostix was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Dermagnostix is headquartered in Freiburg Im Breisgau, Germany. It is registered at Freiburg Im Breisgau, Baden-wurttemberg, Germany.
Dermagnostix was founded in 2018 as a developer of molecular diagnostic tests focused on skin diseases. The PsorX test is provided for detecting psoriasis and atopic dermatitis through the LabDisk-Analyzer, an in vitro diagnostic instrument. Disposable LabDisk cartridges are utilized, containing all necessary reagents for assays. Additional tests for mycosis fungoides and malignant melanoma are under development in the diagnostics sector.
Dermagnostix offers PsorX-LabDisk, LabDisk-Analyzer, and Product Pipeline.
Dermagnostix has 1 investor. Key investors include EIC Fund.
Dermagnostix operates through Dermagnostix Gmbh.